title: Management of arrhythmias in heart failure. What a practicing physician should know in the current times.
abstract: Arrhythmias play a significant role in the mortality and morbidity as well as hospitalizations  of patients who carry a diagnosis of congestive heart failure. With improving survival in a world  of novel medications and devices, an understanding of the pathophysiology and management  of these arrhythmias is crucial. Majority of the basic heart failure medications such as beta-  -blockers, angiotensin converting enzyme inhibitors/aldosterone receptor blockers and aldosterone  antagonists play a pivotal role in prevention of sudden cardiac deaths which can be  a direct/indirect result of these arrhythmias. Anti-arrhythmic drugs and implantable cardioverter-defibrillators were also beneficial in selected patients. Innovative electrophysiological techniques  need to be considered in special situations.
authors.affiliation: Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.
authors.forename: Rajesh
authors.initials: R
authors.lastname: Ramineni
authors.forename: Mani Kumar
authors.initials: MK
authors.lastname: Bheemarasetti
authors.forename: Adrian
authors.initials: A
authors.lastname: Baranchuk
authors.forename: Tapasya
authors.initials: T
authors.lastname: Mandalapu
authors.forename: Venkat K
authors.initials: VK
authors.lastname: Mukku
authors.forename: Ken
authors.initials: K
authors.lastname: Fujise
authors.forename: Alejandro
authors.initials: A
authors.lastname: Barbagelata
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable; D019317:Evidence-Based Medicine; D058006:General Practice; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000451:Mineralocorticoid Receptor Antagonists